|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/08 | |||
| A61K 47/14 | |||
| A61K 31/5575 | |||
| A61P 27/06 |
| (11) | Number of the document | 2950782 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14746512.4 |
| Date of filing the European patent application | 2014-01-30 | |
| (97) | Date of publication of the European application | 2015-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/013744 |
| Date | 2014-01-30 |
| (87) | Number | WO 2014/120866 |
| Date | 2014-08-07 |
| (30) | Number | Date | Country code |
| 201361759129 P | 2013-01-31 | US |
| (72) |
WONG, Vernon G., US
HU, Mae W., US
HUANG, Glenn T., US
|
| (73) |
Icon Bioscience, Inc.,
1253 Reamwood Avenue, Sunnyvale, CA 94089,
US
|
| (54) | SUSTAINED RELEASE FORMULATIONS FOR THE TREATMENT OF INTRAOCULAR PRESSURE OR GLAUCOMA |
| SUSTAINED RELEASE FORMULATIONS FOR THE TREATMENT OF INTRAOCULAR PRESSURE OR GLAUCOMA |